每经头条（nbdtoutiao）——对话马斯克脑机接口"一号受试者"：大脑植入芯片23个月，我正重新夺回 人生的独立 （记者 王晓波） 截至发稿，奥比中光市值为347亿元。 每经AI快讯，奥比中光（SH 688322，收盘价：86.5元）12月26日晚间发布公告称，公司限售股份约 2643.61万股将于2026年1月7日解禁并上市流通，占公司总股本比例为6.59%。 2024年1至12月份，奥比中光的营业收入构成为：AIoT占比52.82%，生物识别占比40.93%，工业三维测 量占比4.69%，其他占比0.92%，其他业务占比0.64%。 ...

每经AI快讯，奥比中光（SH 688322，收盘价：82元）12月11日晚间发布公告称，公司第二届第二十二 次董事会会议于2025年12月11日在公司会议室以现场结合通讯表决方式召开。会议审议了《关于修订 < 公司章程> 的议案》等文件。 2024年1至12月份，奥比中光的营业收入构成为：AIoT占比52.82%，生物识别占比40.93%，工业三维测 量占比4.69%，其他占比0.92%，其他业务占比0.64%。 （记者 曾健辉） 截至发稿，奥比中光市值为329亿元。 每经头条（nbdtoutiao）——专访管涛：美国政府经济贸易政策正逐渐动摇美元本位国际货币体系，利 多因素下人民币汇率有可能破7 ...

Company Overview - Aobi Zhongguang (SH 688322) announced the convening of its 2025 second board meeting on November 28, 2023, to discuss the proposal for the reappointment of the accounting firm for the 2025 fiscal year [1] - The current market capitalization of Aobi Zhongguang is 33.1 billion yuan [1] Revenue Composition - For the fiscal year 2024, Aobi Zhongguang's revenue composition is as follows: - AIoT accounts for 52.82% - Biometric recognition accounts for 40.93% - Industrial 3D measurement accounts for 4.69% - Other businesses account for 0.92% - Additional other business accounts for 0.64% [1]

Group 1 - The core point of the article is that Aobo Zhongguang (SH 688322) held its 20th meeting of the second board of directors on October 24, 2025, to discuss the conditions for the second vesting period of the 2022 restricted stock incentive plan [1] - For the year 2024, Aobo Zhongguang's revenue composition is as follows: AIoT accounts for 52.82%, biometric recognition accounts for 40.93%, industrial 3D measurement accounts for 4.69%, and other businesses account for 1.56% [1] - As of the time of reporting, Aobo Zhongguang has a market capitalization of 34.4 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion US dollars this year, indicating a hot secondary market for biomedicine [1] - There is a discussion on why fundraising in the primary market is facing challenges despite the active secondary market, as highlighted by the conversation with Lu Gang, a partner at Chuangdong Investment [1]

Group 1 - The company, Aobo Zhongguang, announced a share buyback of approximately 120,000 shares, representing 0.03% of its total share capital, with a total expenditure of about 10.01 million RMB [1][1][1] - The share buyback occurred at a price range of 82 to 86.5 RMB per share [1][1][1] - As of the report, Aobo Zhongguang's market capitalization stands at 32.4 billion RMB [1][1][1] Group 2 - For the fiscal year 2024, Aobo Zhongguang's revenue composition is as follows: AIoT accounts for 52.82%, biometric recognition for 40.93%, industrial 3D measurement for 4.69%, and other businesses for 1.56% [1][1][1]

Group 1 - The core point of the article is that Aibijungguang (SH 688322) announced a board meeting to discuss a share repurchase plan and provided a breakdown of its revenue composition for 2024 [1][1][1] Group 2 - The company will hold its 19th board meeting on October 13, 2025, to review the share repurchase proposal [1] - For the year 2024, the revenue composition is as follows: AIoT 52.82%, biometric recognition 40.93%, industrial 3D measurement 4.69%, other businesses 0.92%, and miscellaneous 0.64% [1][1][1] - As of the report, the market capitalization of Aibijungguang is 33.1 billion yuan [1]

Core Viewpoint - The company, Aibijungguang, announced a board meeting to discuss a revised proposal for issuing A-shares to specific investors in 2025, indicating strategic financial planning and potential capital raising efforts [1] Financial Performance - For the year 2024, the revenue composition of Aibijungguang is as follows: AIoT accounts for 52.82%, biometric recognition for 40.93%, industrial 3D measurement for 4.69%, and other businesses for 1.56% combined [1] Market Position - As of the report, Aibijungguang has a market capitalization of 35.2 billion yuan, reflecting its valuation in the current market [1]